What is the current annual EBITDA of HUM?

As of today, HUM annual EBITDA is $2.38B

What is 1-year change in HUM annual EBITDA?

HUM annual EBITDA is down -11.53% year-over-year

What is 3-year change in HUM annual EBITDA?

HUM annual EBITDA is down -46.09% over the past 3 years

How far is HUM annual EBITDA from its all-time high?

HUM annual EBITDA is currently -54.39% below its historical high of $5.22B set on December 31, 2020

How does HUM annual EBITDA rank versus sector peers?

HUM annual EBITDA is higher than 95.66% of companies in Healthcare sector

When is HUM next annual earnings release?

As of today, the next annual earnings release for HUM has not been scheduled

What is the current quarterly EBITDA of HUM?

As of today, HUM quarterly EBITDA is $403.00M

What is HUM quarterly EBITDA most recent change?

HUM quarterly EBITDA was down -64.65% on September 30, 2026

What is 1-year change in HUM quarterly EBITDA?

HUM quarterly EBITDA is up +19.23% year-over-year

How far is HUM quarterly EBITDA from its all-time high?

HUM quarterly EBITDA is currently -85.27% below its historical high of $2.74B set on June 30, 2020

How does HUM quarterly EBITDA rank versus sector peers?

HUM quarterly EBITDA is higher than 93.90% of companies in Healthcare sector

When is HUM next earnings release?

As of today, the next earnings release for HUM has not been scheduled

What is the current TTM EBITDA of HUM?

As of today, HUM TTM EBITDA is $2.52B

What is HUM TTM EBITDA most recent change?

HUM TTM EBITDA was up +2.65% on September 30, 2026

What is 1-year change in HUM TTM EBITDA?

HUM TTM EBITDA is down -2.29% year-over-year

How far is HUM TTM EBITDA from its all-time high?

HUM TTM EBITDA is currently -59.74% below its historical high of $6.25B set on September 30, 2020

How does HUM TTM EBITDA rank versus sector peers?

HUM TTM EBITDA is higher than 95.64% of companies in Healthcare sector

When is HUM next earnings release?

As of today, the next earnings release for HUM has not been scheduled

Humana Inc. (HUM) EBITDA History & Chart Since 1980

Annual EBITDA

$2.38B$310.00M-11.53%

December 31, 2025

Summary

Current Value: As of today, HUM annual EBITDA is $2.38B, down -11.53% on December 31, 2025
Historical Performance: HUM annual EBITDA is down -46.09% over the past 3 years, down -54.39% over the past 5 years
All-Time High Comparison: HUM annual EBITDA is currently -54.39% below its historical high of $5.22B set on December 31, 2020
3-Year Low Comparison: HUM annual EBITDA is at its 3-year low
Sector Comparison: HUM annual EBITDA is higher than 95.66% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

HUM Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$2.38B	-11.5%	-46.1%	-54.4%	+18.2%
Quarterly EBITDA	Sep 30, 26	$403.00M	+19.2%	-69.8%	-77.8%	-47.9%
TTM EBITDA	Sep 30, 26	$2.52B	-2.3%	-47.6%	-30.8%	+5.3%
Price	Nov 6, 26	$433.74	+72.7%	-11.0%	-4.3%	+401.0%
PE Ratio	Nov 6, 26	42.22	+79.4%	+109.0%	+92.8%	+283.8%
Annual Revenue	Dec 31, 25	$129.71B	+10.1%	+39.6%	+68.0%	+283.0%
Annual EPS	Dec 31, 25	$9.83	-1.5%	-55.5%	-61.2%	+51.9%
	Dec 31, 25	$1.56B	-9.7%	-56.4%	-66.2%	-11.1%
Annual Net Income	Dec 31, 25	$1.20B	-0.9%	-57.1%	-64.3%	+9.4%

EBITDA Highs

HUM Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$4.41B	N/A	-46.1%
5Y	$5.22B	N/A	-54.4%
All	$5.22B	Dec 31, 20	-54.4%

EBITDA Lows

HUM Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$2.38B	Dec 31, 25	at low
5Y	$2.38B	Dec 31, 25	at low
All	-$280.00M	Dec 31, 99	+949.6%

EBITDA History

Year	Value	Change
2025	$2.38B	-11.5%
2024	$2.69B	-37.5%
2023	$4.30B	-2.6%
2022	$4.41B	+8.5%
2021	$4.07B	-22.0%
2020	$5.22B	+29.4%
2019	$4.03B	+55.2%
2018	$2.60B	-42.4%
2017	$4.51B	+123.4%
2016	$2.02B	-29.9%
2015	$2.88B	+9.9%
2014	$2.62B	+11.6%
2013	$2.35B	+4.4%
2012	$2.25B	-11.4%
2011	$2.54B	+26.1%
2010	$2.01B	+8.7%
2009	$1.85B	+52.7%
2008	$1.21B	-17.7%
2007	$1.47B	+61.9%
2006	$910.68M	+65.4%
2005	$550.57M	+296.6%

Year	Value	Change
1999	-$280.00M	-184.6%
1998	$331.00M	-12.4%
1997	$378.00M	+225.9%
1996	$116.00M	-67.6%
1995	$358.00M	+16.6%
1994	$307.00M	+61.6%
1993	$190.00M	-65.4%
1992	$549.00M	-32.3%
1991	$811.00M	+11.2%
1990	$729.63M	+20.0%
1989	$608.20M	+10.7%
1988	$549.29M	+7.7%
1987	$510.23M	+89.2%
1986	$269.73M	-48.5%
1985	$523.44M	+15.6%
1984	$452.81M	+18.1%
1983	$383.45M	+25.3%
1982	$306.04M	+24.3%
1981	$246.15M	+37.4%
1980	$179.09M	-

FAQ

What is the current annual EBITDA of HUM?: As of today, HUM annual EBITDA is $2.38B
What is 1-year change in HUM annual EBITDA?: HUM annual EBITDA is down -11.53% year-over-year
What is 3-year change in HUM annual EBITDA?: HUM annual EBITDA is down -46.09% over the past 3 years
How far is HUM annual EBITDA from its all-time high?: HUM annual EBITDA is currently -54.39% below its historical high of $5.22B set on December 31, 2020
How does HUM annual EBITDA rank versus sector peers?: HUM annual EBITDA is higher than 95.66% of companies in Healthcare sector
When is HUM next annual earnings release?: As of today, the next annual earnings release for HUM has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$403.00M$737.00M-64.65%

September 30, 2026

Summary

Current Value: As of today, HUM quarterly EBITDA is $403.00M, down -64.65% on September 30, 2026
Historical Performance: HUM quarterly EBITDA is up +19.23% year-over-year, down -69.77% over the past 3 years
All-Time High Comparison: HUM quarterly EBITDA is currently -85.27% below its historical high of $2.74B set on June 30, 2020
3-Year Low Comparison: HUM quarterly EBITDA is +149.33% above its 3-year low of -$817.00M reached on December 31, 2025
Sector Comparison: HUM quarterly EBITDA is higher than 93.90% of companies in Healthcare sector

Performance

HUM Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$403.00M	-64.7%	+19.2%	-69.8%	-77.8%
Annual EBITDA	Dec 31, 25	$2.38B	–	-11.5%	-46.1%	-54.4%
TTM EBITDA	Sep 30, 26	$2.52B	+2.6%	-2.3%	-47.6%	-30.8%
Price	Nov 6, 26	$433.74	+18.1%	+72.7%	-11.0%	-4.3%
PE Ratio	Nov 6, 26	42.22	+21.4%	+79.4%	+109.0%	+92.8%
Quarterly Revenue	Sep 30, 26	$41.16B	+0.7%	+26.1%	+55.8%	+89.2%
Quarterly EPS	Sep 30, 26	$1.33	-76.8%	-17.7%	-80.2%	-88.8%
	Sep 30, 26	$216.00M	-77.3%	+61.2%	-80.3%	-86.8%
Quarterly Net Income	Sep 30, 26	$161.00M	-76.8%	-17.0%	-80.6%	-89.5%

Quarterly EBITDA Highs

HUM Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.79B	Mar 31, 26	-77.5%
3Y	$1.91B	Mar 31, 25	-78.9%
5Y	$1.91B	Mar 31, 25	-78.9%
All	$2.74B	Jun 30, 20	-85.3%

Quarterly EBITDA Lows

HUM Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	-$817.00M	Dec 31, 25	+149.3%
3Y	-$817.00M	Dec 31, 25	+149.3%
5Y	-$817.00M	Dec 31, 25	+149.3%
All	-$817.00M	Dec 31, 25	+149.3%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$403.00M	-64.6%
Jun 2026	$1.14B	-36.3%
Mar 2026	$1.79B	+319.0%
Dec 2025	-$817.00M	-341.7%
Sep 2025	$338.00M	-64.5%
Jun 2025	$952.00M	-50.1%
Mar 2025	$1.91B	+406.4%
Dec 2024	-$622.00M	-169.6%
Sep 2024	$894.00M	-23.0%
Jun 2024	$1.16B	-7.6%
Mar 2024	$1.26B	+455.8%
Dec 2023	-$353.00M	-126.5%
Sep 2023	$1.33B	-10.4%
Jun 2023	$1.49B	-18.8%
Mar 2023	$1.83B	+1,154.8%
Dec 2022	$146.00M	-90.3%
Sep 2022	$1.51B	+13.5%
Jun 2022	$1.33B	-6.6%
Mar 2022	$1.43B	+963.4%
Dec 2021	$134.00M	-92.6%
Sep 2021	$1.82B	+100.1%
Jun 2021	$908.00M	-24.8%
Mar 2021	$1.21B	+505.4%
Dec 2020	-$298.00M	-115.6%
Sep 2020	$1.92B	-30.0%
Jun 2020	$2.74B	+217.4%
Mar 2020	$862.00M	+17.6%
Dec 2019	$733.00M	-30.0%
Sep 2019	$1.05B	-23.5%
Jun 2019	$1.37B	+55.2%
Mar 2019	$882.00M	+54.7%
Dec 2018	$570.00M	-44.8%
Sep 2018	$1.03B	+592.6%
Jun 2018	$149.00M	-82.4%
Mar 2018	$846.00M	+36.9%
Dec 2017	$618.00M	-32.8%
Sep 2017	$919.00M	-20.8%
Jun 2017	$1.16B	-35.7%
Mar 2017	$1.81B	+589.7%
Dec 2016	-$369.00M	-136.2%
Sep 2016	$1.02B	+35.5%
Jun 2016	$752.00M	+22.3%
Mar 2016	$615.00M	+71.8%
Dec 2015	$358.00M	-52.6%
Sep 2015	$755.00M	-16.8%
Jun 2015	$907.00M	+5.7%
Mar 2015	$858.00M	+108.8%
Dec 2014	$411.00M	-38.0%
Sep 2014	$663.00M	-11.8%
Jun 2014	$752.00M	-5.2%
Mar 2014	$793.00M	+1,120.0%
Dec 2013	$65.00M	-90.6%
Sep 2013	$692.00M	-8.7%
Jun 2013	$758.00M	-8.9%
Mar 2013	$832.00M	+117.8%
Dec 2012	$382.00M	-49.3%
Sep 2012	$753.00M	+16.6%
Jun 2012	$646.00M	+38.0%
Mar 2012	$468.00M	+19.7%
Dec 2011	$390.82M	-49.5%
Sep 2011	$773.30M	-3.5%
Jun 2011	$801.61M	+40.1%
Mar 2011	$572.28M	+137.7%
Dec 2010	$240.80M	-64.9%
Sep 2010	$686.85M	+13.5%

Month	Value	Change
Jun 2010	$605.14M	+26.2%
Mar 2010	$479.68M	+2.4%
Dec 2009	$468.39M	-11.9%
Sep 2009	$531.44M	+6.2%
Jun 2009	$500.43M	+42.3%
Mar 2009	$351.78M	+9.6%
Dec 2008	$320.85M	-5.3%
Sep 2008	$338.99M	-10.4%
Jun 2008	$378.47M	+116.4%
Mar 2008	$174.89M	-57.1%
Dec 2007	$407.22M	-21.8%
Sep 2007	$520.75M	+32.2%
Jun 2007	$393.85M	+158.6%
Mar 2007	$152.29M	-45.7%
Dec 2006	$280.60M	-2.2%
Sep 2006	$287.05M	+62.3%
Jun 2006	$176.92M	+6.5%
Mar 2006	$166.11M	+25.0%
Dec 2005	$132.94M	+31.9%
Sep 2005	$100.80M	-37.4%
Jun 2005	$161.07M	+6.7%
Mar 2005	$150.94M	+56.7%
Dec 2004	$96.33M	-39.3%
Sep 2004	$158.71M	+6.1%
Jun 2004	$149.52M	+15.8%
Mar 2004	$129.09M	+2.2%
Dec 2003	$126.26M	+4.8%
Sep 2003	$120.52M	-9.1%
Jun 2003	$132.64M	+44.1%
Mar 2003	$92.07M	+232.8%
Dec 2002	$27.67M	-74.3%
Sep 2002	$107.48M	+10.9%
Jun 2002	$96.94M	-1.7%
Mar 2002	$98.58M	-7.8%
Dec 2001	$106.88M	+21.0%
Sep 2001	$88.30M	+13.3%
Jun 2001	$77.93M	-3.5%
Mar 2001	$80.78M	+75.6%
Dec 1997	$46.00M	+58.6%
Sep 1997	$29.00M	+11.5%
Jun 1997	$26.00M	-3.7%
Mar 1997	$27.00M	+8.0%
Dec 1996	$25.00M	-7.4%
Sep 1996	$27.00M	0.0%
Jun 1996	$27.00M	-10.0%
Mar 1996	$30.00M	+3.4%
Dec 1995	$29.00M	+61.1%
Sep 1995	$18.00M	+5.9%
Jun 1995	$17.00M	0.0%
Mar 1995	$17.00M	-93.7%
Dec 1994	$269.00M	+1,821.4%
Sep 1994	$14.00M	-65.0%
Jun 1994	$40.00M	+207.7%
Mar 1994	$13.00M	0.0%
Dec 1993	$13.00M	0.0%
Sep 1993	$13.00M	-7.1%
Jun 1993	$14.00M	0.0%
Mar 1993	$14.00M	-81.3%
Nov 1992	$75.00M	+87.5%
Aug 1992	$40.00M	-56.5%
May 1992	$92.00M	+4.5%
Feb 1992	$88.00M	-1.1%
Nov 1991	$89.00M	+6.0%
Nov 1990	$84.00M	-

FAQ

What is the current quarterly EBITDA of HUM?: As of today, HUM quarterly EBITDA is $403.00M
What is HUM quarterly EBITDA most recent change?: HUM quarterly EBITDA was down -64.65% on September 30, 2026
What is 1-year change in HUM quarterly EBITDA?: HUM quarterly EBITDA is up +19.23% year-over-year
How far is HUM quarterly EBITDA from its all-time high?: HUM quarterly EBITDA is currently -85.27% below its historical high of $2.74B set on June 30, 2020
How does HUM quarterly EBITDA rank versus sector peers?: HUM quarterly EBITDA is higher than 93.90% of companies in Healthcare sector
When is HUM next earnings release?: As of today, the next earnings release for HUM has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$2.52B$65.00M+2.65%

September 30, 2026

Summary

Current Value: As of today, HUM TTM EBITDA is $2.52B, up +2.65% on September 30, 2026
Historical Performance: HUM TTM EBITDA is down -2.29% year-over-year, down -47.59% over the past 3 years
All-Time High Comparison: HUM TTM EBITDA is currently -59.74% below its historical high of $6.25B set on September 30, 2020
3-Year Low Comparison: HUM TTM EBITDA is +11.18% above its 3-year low of $2.26B reached on March 31, 2026
Sector Comparison: HUM TTM EBITDA is higher than 95.64% of companies in Healthcare sector

Performance

HUM Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$2.52B	+2.6%	-2.3%	-47.6%	-30.8%
Annual EBITDA	Dec 31, 25	$2.38B	–	-11.5%	-46.1%	-54.4%
Quarterly EBITDA	Sep 30, 26	$403.00M	-64.7%	+19.2%	-69.8%	-77.8%
Price	Nov 6, 26	$433.74	+18.1%	+72.7%	-11.0%	-4.3%
PE Ratio	Nov 6, 26	42.22	+21.4%	+79.4%	+109.0%	+92.8%
TTM Revenue	Sep 30, 26	$154.19B	+5.8%	+22.0%	+50.6%	+87.7%
TTM EPS	Sep 30, 26	$10.27	-2.7%	-3.7%	-57.4%	-50.4%
	Sep 30, 26	$1.75B	+4.9%	+2.8%	-55.1%	-40.7%
TTM Net Income	Sep 30, 26	$1.26B	-2.5%	-2.6%	-58.0%	-52.8%

TTM EBITDA Highs

HUM TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$2.57B	N/A	-2.3%
3Y	$4.80B	N/A	-47.6%
5Y	$4.98B	Jun 30, 23	-49.5%
All	$6.25B	Sep 30, 20	-59.7%

TTM EBITDA Lows

HUM TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$2.26B	Mar 31, 26	+11.2%
3Y	$2.26B	Mar 31, 26	+11.2%
5Y	$2.26B	Mar 31, 26	+11.2%
All	$53.00M	Mar 31, 94	+4645.3%

TTM EBITDA History

Month	Value	Change
Sep 2026	$2.52B	+2.7%
Jun 2026	$2.45B	+8.3%
Mar 2026	$2.26B	-4.9%
Dec 2025	$2.38B	-7.6%
Sep 2025	$2.57B	-17.8%
Jun 2025	$3.13B	-6.3%
Mar 2025	$3.34B	+24.2%
Dec 2024	$2.69B	-9.1%
Sep 2024	$2.96B	-12.9%
Jun 2024	$3.40B	-8.8%
Mar 2024	$3.72B	-13.4%
Dec 2023	$4.30B	-10.4%
Sep 2023	$4.80B	-3.6%
Jun 2023	$4.98B	+3.3%
Mar 2023	$4.82B	+9.2%
Dec 2022	$4.41B	+0.3%
Sep 2022	$4.40B	-6.5%
Jun 2022	$4.71B	+9.9%
Mar 2022	$4.28B	+5.3%
Dec 2021	$4.07B	+11.9%
Sep 2021	$3.64B	-2.7%
Jun 2021	$3.73B	-32.9%
Mar 2021	$5.56B	+6.6%
Dec 2020	$5.22B	-16.5%
Sep 2020	$6.25B	+16.2%
Jun 2020	$5.38B	+34.1%
Mar 2020	$4.01B	-0.5%
Dec 2019	$4.03B	+4.2%
Sep 2019	$3.87B	+0.4%
Jun 2019	$3.85B	+46.3%
Mar 2019	$2.63B	+1.4%
Dec 2018	$2.60B	-1.8%
Sep 2018	$2.65B	+4.5%
Jun 2018	$2.53B	-28.6%
Mar 2018	$3.54B	-21.3%
Dec 2017	$4.51B	+28.1%
Sep 2017	$3.52B	-2.8%
Jun 2017	$3.62B	+12.7%
Mar 2017	$3.21B	+59.1%
Dec 2016	$2.02B	-26.5%
Sep 2016	$2.74B	+10.6%
Jun 2016	$2.48B	-5.9%
Mar 2016	$2.64B	-8.4%
Dec 2015	$2.88B	-1.8%
Sep 2015	$2.93B	+3.2%
Jun 2015	$2.84B	+5.8%
Mar 2015	$2.68B	+2.5%
Dec 2014	$2.62B	+15.2%
Sep 2014	$2.27B	-1.3%
Jun 2014	$2.30B	-0.3%
Mar 2014	$2.31B	-1.7%
Dec 2013	$2.35B	-11.9%
Sep 2013	$2.66B	-2.2%
Jun 2013	$2.73B	+4.3%
Mar 2013	$2.61B	+16.2%
Dec 2012	$2.25B	-0.4%
Sep 2012	$2.26B	-0.9%
Jun 2012	$2.28B	-6.4%
Mar 2012	$2.43B	-4.1%
Dec 2011	$2.54B	+6.3%
Sep 2011	$2.39B	+3.8%
Jun 2011	$2.30B	+9.3%
Mar 2011	$2.11B	+4.6%
Dec 2010	$2.01B	-10.2%
Sep 2010	$2.24B	+7.5%

Month	Value	Change
Jun 2010	$2.08B	+5.3%
Mar 2010	$1.98B	+6.9%
Dec 2009	$1.85B	+8.7%
Sep 2009	$1.70B	+12.7%
Jun 2009	$1.51B	+8.8%
Mar 2009	$1.39B	+14.6%
Dec 2008	$1.21B	-6.6%
Sep 2008	$1.30B	-12.3%
Jun 2008	$1.48B	-1.0%
Mar 2008	$1.50B	+1.5%
Dec 2007	$1.47B	+9.4%
Sep 2007	$1.35B	+21.0%
Jun 2007	$1.11B	+24.2%
Mar 2007	$896.85M	-1.5%
Dec 2006	$910.68M	+19.4%
Sep 2006	$763.03M	+32.3%
Jun 2006	$576.77M	+2.8%
Mar 2006	$560.92M	+2.8%
Dec 2005	$545.75M	+7.2%
Sep 2005	$509.13M	-10.2%
Jun 2005	$567.05M	+2.1%
Mar 2005	$555.49M	+4.1%
Dec 2004	$533.64M	-5.3%
Sep 2004	$563.57M	+7.3%
Jun 2004	$525.39M	+3.3%
Mar 2004	$508.51M	+7.9%
Dec 2003	$471.50M	+26.4%
Sep 2003	$372.90M	+3.6%
Jun 2003	$359.86M	+11.0%
Mar 2003	$324.16M	-2.0%
Dec 2002	$330.66M	-19.3%
Sep 2002	$409.88M	+4.9%
Jun 2002	$390.69M	+5.1%
Mar 2002	$371.68M	+5.0%
Dec 2001	$353.88M	+43.3%
Sep 2001	$247.00M	+55.6%
Jun 2001	$158.71M	+96.5%
Mar 2001	$80.78M	-36.9%
Dec 1997	$128.00M	+19.6%
Sep 1997	$107.00M	+1.9%
Jun 1997	$105.00M	-0.9%
Mar 1997	$106.00M	-2.8%
Dec 1996	$109.00M	-3.5%
Sep 1996	$113.00M	+8.7%
Jun 1996	$104.00M	+10.6%
Mar 1996	$94.00M	+16.0%
Dec 1995	$81.00M	-74.8%
Sep 1995	$321.00M	+1.3%
Jun 1995	$317.00M	-6.8%
Mar 1995	$340.00M	+1.2%
Dec 1994	$336.00M	+320.0%
Sep 1994	$80.00M	+1.3%
Jun 1994	$79.00M	+49.1%
Mar 1994	$53.00M	-1.9%
Dec 1993	$54.00M	-53.4%
Sep 1993	$116.00M	-18.9%
Jun 1993	$143.00M	-35.3%
Mar 1993	$221.00M	-25.1%
Nov 1992	$295.00M	-4.5%
Aug 1992	$309.00M	+14.9%
May 1992	$269.00M	+52.0%
Feb 1992	$177.00M	+98.9%
Nov 1991	$89.00M	+6.0%
Nov 1990	$84.00M	-

FAQ

What is the current TTM EBITDA of HUM?: As of today, HUM TTM EBITDA is $2.52B
What is HUM TTM EBITDA most recent change?: HUM TTM EBITDA was up +2.65% on September 30, 2026
What is 1-year change in HUM TTM EBITDA?: HUM TTM EBITDA is down -2.29% year-over-year
How far is HUM TTM EBITDA from its all-time high?: HUM TTM EBITDA is currently -59.74% below its historical high of $6.25B set on September 30, 2020
How does HUM TTM EBITDA rank versus sector peers?: HUM TTM EBITDA is higher than 95.64% of companies in Healthcare sector
When is HUM next earnings release?: As of today, the next earnings release for HUM has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

HUM Official Website www.humana.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/49071/000004907126000005/0000049071-26-000005-index.htm
HUM Profile on Yahoo Finance finance.yahoo.com/quote/HUM
HUM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hum